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Adenovirus E1A induces cell proliferation, oncogenic transformation and promotes viral replication
through interaction with p300/CBP, TRRAP/p400 multi-protein complex and the retinoblastoma (pRb)
family proteins through distinct domains in the E1A N-terminal region. The C-terminal region of E1A
suppresses E1A/Ras co-transformation and interacts with FOXK1/K2, DYRK1A/1B/HAN11 and CtBP1/2
(CtBP) protein complexes. To speciﬁcally dissect the role of CtBP interaction with E1A, we engineered a
mutation (DL-AS) within the CtBP-binding motif, PLDLS, and investigated the effect of the mutation on
immortalization and Ras cooperative transformation of primary cells and viral replication. Our results
suggest that CtBP–E1A interaction suppresses immortalization and Ras co-operative transformation of
primary rodent epithelial cells without signiﬁcantly inﬂuencing the tumorigenic activities of transformed
cells in immunodeﬁcient and immunocompetent animals. During productive infection, CtBP–E1A
interaction enhances viral replication in human cells. Between the two CtBP family proteins, CtBP2
appears to restrict viral replication more than CtBP1 in human cells.
& 2013 Elsevier Inc. All rights reserved.Introduction
HAdv E1A has been widely used as a prototypical viral
oncogene for dissecting the molecular mechanisms of cell prolif-
eration and cell transformation. The E1A gene codes for two major
proteins that are expressed from two alternatively spliced mRNA
species namely the 13S and 12S. The 13S mRNA codes for a 289
amino acids protein (L-E1A) and the 12S mRNA codes for a 243
amino acids protein (S-E1A). The 13S product differs from the 12S
product by the presence of a unique 46 amino acids internal
sequence. Both E1A protein products can immortalize primary
cells and can transform them in co-operation with other viral and
cellular oncogenes (Graham et al., 1974; Houweling et al., 1980;
Ruley, 1983; Zerler et al., 1986). The transforming activities of E1A
have been linked to the interaction with various cellular protein
complexes (reviewed in Chinnadurai, 2011; Pelka et al., 2008).
Through interaction with the cellular protein complexes, E1A
deregulates the cell cycle and induces cell transformation. These
cellular protein complexes include the histone acetyl transferases,
p300/CBP, the TRRAP/p400/GCN5 multi-protein chromatin remo-
deling complex and the retinoblastoma (Rb) tumor suppressorll rights reserved.
.family proteins (reviewed in Chinnadurai, 2011). The interaction of
E1A with Rb results in the activation of E2F family of transcription
factors (Chellappan et al., 1992) which activate the S-phase genes
resulting in cell cycle progression. The E1A gene also reprograms host
cell gene expression to block cell differentiation (reviewed in Berk,
2005; Frisch and Mymryk, 2002; Gallimore and Turnell, 2001).
In addition to the transforming function, the E1A proteins also
possess a paradoxical transformation suppression function that is
encoded within the C-terminal region (reviewed by Chinnadurai,
2011; Yousef et al., 2012). The E1A C-terminal mutants induced
high frequency transformation of BRK cells in co-operation with
the activated Ras oncogene (Boyd et al., 1993; Douglas et al., 1991;
Fischer and Quinlan, 1998; Schaeper et al., 1995; Subramanian
et al., 1989). In addition, the transformed cells expressing the
C-terminal mutants were highly tumorigenic in athymic mice and
syngeneic rats whereas the wild-type E1A-transformed cells were
less tumorigenic in athymic mice and non-tumorigenic in syn-
geneic rats. Moreover, the E1A mutant transformed cells were
highly metastatic when injected into athymic mice. At present the
mechanisms by which the C-terminus of E1A suppresses the cell
transformation, tumorigenesis and tumor metastasis are not fully
understood. Our laboratory identiﬁed and cloned the ﬁrst cellular
protein, C-terminal binding protein 1 (CtBP1) that interacts with
the C-terminus of E1A through a conserved motif, PLDLS (Boyd
et al., 1993; Schaeper et al., 1995). E1A also interacts with a highly
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CtBP1/2 (collectively designated as CtBP), the C-terminal region of
E1A interacts with two other protein complexes, DYRK1A/1B/
HAN11 (designated here as DYRK1/HAN11) and FOXK1/K2 through
distinct conserved domains (Komorek et al., 2010; Zhang et al.,
2001). E1A mutants that are individually defective in interaction
with DYRK1A/1B/HAN11 and FOXK1/K2 complexes exhibit hyper
transforming activities (Komorek et al., 2010). To understand the
importance of interaction of CtBP with E1A C-terminus in cell
transformation and virus replication, we mutated E1A C-terminus
within the CtBP-binding motif and characterized the effect of
interaction of E1A with CtBP in cell transformation and virus
replication. We found that the interaction of E1A with CtBP
reduced immortalization and Ras co-operative transformation in
primary rodent epithelial (BRK) cells while enhancing virus
replication in human cells.Results
The effect of CtBP interaction with E1A on oncogenic transfor-
mation was previously examined using a mutant (dl1135) that
contains a deletion of sequences coding for 14 residues encom-
passing the CtBP binding motif (Boyd et al., 1993). The discovery of
additional protein interactions and the mapping of their interac-
tion regions within E1A (Komorek et al., 2010) indicated that
dl1135 is defective in interaction with both the DYRK1/HAN11 and
CtBP1/2 complexes. To investigate the role of CtBP in E1A-
mediated cell transformation and in virus replication, we con-
structed an E1A mutant that results in two amino acid substitution
within the CtBP-binding motif, PLDLS (PLDLS-PLASS). The inter-
action of cellular proteins with the newly engineered mutant
(E1A12S-DL-AS) was determined by immunoprecipitation/Wes-
tern-blot analysis of E1A proteins from HeLa cells transfected with
different E1A12S plasmids expressing wt S-E1A or mutant proteins
(Fig. 1A) or BRK cells transformed with E1A-12S and the Ras
oncogene (Fig. 1B). As expected, the mutant DL-AS made com-
parable level of protein as wt S-E1A and did not bind to CtBP1 and
CtBP2 (Fig. 1A and B). However, it interacted as well as wt S-E1A
with FOXK1 and DYRK1A, suggesting that the newly engineered
E1A mutant is deﬁcient in interaction only with CtBP.Lysate IP:M58
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Fig. 1. Interaction of cellular proteins with E1A C-terminal region. (A) HeLa cells were
transfection cells were lysed and immunoprecipitated with E1A speciﬁc antibody M58. T
(B) Western blot analysis of E1A immunoprecipitated from BRK cells transformed with E
DYRK1A and E1A (M58). Background protein bands that migrate slower than CtBP1/CtBInteraction with CtBP suppresses the immortalization activity of E1A
The E1A gene has been shown to immortalize primary rodent
epithelial cells and efﬁciently transform them in cooperation with
the Ras oncogene (Graham et al., 1974; Houweling et al., 1980;
Ruley, 1983; Zerler et al., 1986). Previous studies have shown that
different mutations within the C-terminal region of E1A resulted
in a hyper transformation phenotype and also in an overall defect
in immortalization (Douglas et al., 1991; Quinlan and Douglas,
1992; Subramanian et al., 1991, 2007). To determine the speciﬁc
effect of CtBP on the immortalization function of E1A, we trans-
duced retrovirus (pBABE) vectors that express E1A12S wt or
DL-AS mutant or mutants that are speciﬁcally defective in
FOXK1/K2 interaction (12S-dl1132)) or defective in DYRK1/HAN11
binding (12S-dl1133) into primary BRK cells and subjected them to
dominant selection with puromycin. The resulting colonies were
quantiﬁed (Fig. 2A). As expected, there was no colony in cells
transduced with pBABE vector while transduction of E1A-12S wt
resulted in signiﬁcant colony formation. Interestingly, BRK cells
transduced with 12S-DL-AS or 12S-dl1133 contained more colo-
nies than cells transduced with E1A12S wt. Cells transduced with
12S-dl1132 formed only about one half of number of colonies
induced by E1A12S wt. These results suggest that the interaction
of CtBP as well as DYRK1/HAN11 may negatively regulate the
immortalization activity of E1A while the interaction of FOXK1/K2
transcription factors may enhance the immortalization function.
Since the colony formation assay may not exclude the possibility of
abortive colonies, we also tested the ability of isolated colonies to
establish as immortalized cell lines (Fig. 2B). Among the mutants
tested for colony establishment, 35% of colonies induced by 12S-
DL-AS established as cell lines while less than 10% of 12S wt-
induced colonies established. Mutant dl1133 induced colonies
established less than 12S-wt colonies did. A higher percent of
colonies (17%) from cells transduced with dl1132 established
compared to cells transduced with E1A12S wt. To ascertain the
cells transduced with different E1A retrovirus vectors express E1A
proteins, two pooled cell lines in each category were analyzed by
Western blot analysis (Fig. 2C). The colony establishment assay
clearly showed that the 12S-DL-AS mutant immortalized better
than wt 12S as well as other C-terminal mutants. Taken together
these results suggest that the interaction of CtBP with E1A
C-terminus suppresses the immortalization function of E1A.CtBP1
E1A
CtBP2
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transfected with E1A12S wt and mutant DL-AS in pLPC vectors and 24 h after
he proteins were separated by SDS-PAGE (4–12%) and analyzed by Western blotting.
1A and Ras. The blots were probed with antibodies speciﬁc to CtBP1, CtBP2, FOXK1,
P2 bands appear to correspond to IgH bands.
Fig. 2. Effect of E1A C-terminal mutants on immortalization of BRK cells. BRK cells
were plated in six-well plates and infected with retrovirus vectors expressing
E1A12S wt, E1A12S-DL-AS, E1A12S-dl1132, E1A12S-dl1133 or the empty vector.
Next day, cells were subjected to selection with 0.25 mg/mL of puromycin with
media change every fourth day. On tenth day, cells were stained with crystal violet
and the colonies were quantiﬁed (from three experiments) (A). The colonies
selected with puromycin were also isolated (24 colonies each time) and plated in
24-well plates and propagated for four weeks and the percentage of established
colonies were calculated (B). The expression of E1A proteins in pooled immorta-
lized cell lines (two different lines in each category designated (A) and (B)) were
determined by western blot analysis (C). The statistical differences were deter-
mined using one-way ANOVA followed by Newman–Keuls Multiple Comparison
Test using GraphPad Prism software. p-value was determined by comparing 12S
with DL-AS, dl1132 and dl1133 mutants. Signiﬁcance was accepted at a value of
npo0.05, nnpo0.01 and nnnpo .001. Fig. 3. Ras cooperative transformation by E1A C-terminal mutants. BRK cells in six-
well plates were transfected with E1A12S wt or mutants along with the activated Ras
oncogene and pcDNA3 vector. The cells were selected with 50 mg/mL of G418 for 10
days, stained with crystal violet and the colonies were counted. The average values
from three independent experiments are plotted (A). Pooled transformed cell lines
were established from transformed colonies that were selected for 10 days with 50
mg/mL of G418, and were trypsinized and passaged three times. 1106 cells in 100 mL
of growth medium without serum were injected subcutaneously into 4 to 6 week-old
female athymic mice (n¼4) and the tumor volumes were measured periodically. The
averages of three experiments are shown (B). The expression of E1A in transformed
cell lines (1106 cell/cell line) was analyzed by western-blotting using M58 Ab (C).
The statistical signiﬁcances were determined as in Fig. 2.
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activity of E1A
Different E1A C-terminal mutants that are deﬁcient in interac-
tion with one or more of the cellular protein complexes have
previously been shown to be hyper-transforming in Ras coopera-
tive transformation assays (Boyd et al., 1993; Douglas et al., 1991;
Schaeper et al., 1995; Subramanian et al., 1989). However, theeffect of E1A mutants that are speciﬁcally deﬁcient in interaction
with CtBP is not known (a previously examined mutant dl1135 is
defective in interaction with both CtBP1/2 and the DYRK1/HAN11
complexes). Here, we examined the effect of E1A12S-DL-AS
mutant on Ras co-operative transformation of BRK cells (Fig. 3).
Cotransfection of 12S-DL-AS with the Ras oncogene resulted in
about twice as many transformed foci as that of Ras and 12S wt.
Other mutants that are individually deﬁcient in interaction in
FOXK1/K2 and DYRK1/HAN11 also resulted in enhanced coopera-
tive transformation while 12S-177-9 that is deﬁcient in interaction
with all three protein complexes induced more transformed foci
(that were also qualitatively more aggressive) compared to other
T. Subramanian et al. / Virology 443 (2013) 313–320316mutants. These results suggest that the interaction of E1A
C-terminus with CtBP also suppresses the frequency of Ras co-
operative transformation.
We have previously reported that BRK cells transformed from
cells transfected with E1A12S wt and Ras were less tumorigenic in
athymic mice than cells transformed with E1A12S C-terminal
truncation mutants and Ras. In syngeneic rats, the transformed
cells expressing E1A C-terminal truncation mutants were highly
tumorigenic while cells transformed with E1A12S wt and Ras were
non-tumorigenic (Subramanian et al., 1989). To evaluate the
tumorigenic potentials of transformed cells that express E1A12S-
DL-AS and Ras, we established pooled cell lines and transplanted
them in athymic mice as well as in new born rats. The tumor
volumes in athymic mice were measured at ﬁve day-intervals
(Fig. 3B) and the tumor incidence in syngeneic rats was noted after
three weeks (Table 2). All mice injected with various cell lines
formed tumors of varying sizes. Among the different cell lines, the
cell line expressing E1A12S-dl1133 (defective in interaction with
DYRK1/HAN11) formed the largest tumors followed by cells thatTable 2
Tumorigenesis of transformed BRK cell lines in syngeneic rats. Pooled transformed
cell lines were established as in Fig. 3B and 1106 cells in 50 mL of growth medium
without serum were injected subcutaneously into 3-day old neonatal Fisher rats.
The animals were monitored for three weeks period for the formation of tumors.
The experiment was repeated three times with 1 litter of new born rats (n¼5–9)
for each cell lines in independent experiments.
Cell line Tumors/pups Percentage
12S+Ras 0/20 0.0
12S-DL-AS+Ras (3)/30 10.0
12S-dl1132+Ras 10/20 50.0
12S-dl1133+Ras 15/17 88.2
12S-177-9+Ras 22/29 75.9
Table 1
Plasmids, retroviral vectors and viral mutants used in the study. Plasmids that
express E1A12S in pUC19 were used in transformation studies. pLPC-based vectors
that express E1A12S were used for transient E1A protein expression. pBABE
(E1A12S)-based retroviral vectors were used in immortalization studies. HAdv5
based adenovirus mutants (genomic E1A) were used in viral replication studies.
The coordinates of E1A mutations are based on the larger 289-amino acid protein
(L-E1A).
Plasmid/viral mutant E1A
background
aa mutated Interaction with
cellular proteins
FOXK DYRK1 CtBP
Plasmids (pUC18/pBABE/
pLPC)
E1A(12S) 12S (243R) – + + +
E1A(12S) dl1132 12S (243R) Δ224–238 − + +
E1A(12S)dl1133 12S (243R) Δ239–254 + − +
E1A(12S)DL-AS 12S (243R) D281L282-
AS
+ + −
E1A(12S)177-9 12 (243R) Δ224–284 − − −
Adenoviruses
HAdv5dl309 Genomic
(12S+13S)
– + + +
HAdv5dl1132 Genomic
(12S+13S)
Δ224–238 − + +
HAdv5dl1133 Genomic
(12S+13S)
Δ239–254 + − +
HAdv5DL-AS Genomic
(12S+13S)
D281L282-
AS
+ + −
HAdv5177-9 Genomic
(12S+13S)
Δ224–284 − − −express E1A12S-177-9 (defective in binding with all three known
C-terminus interacting protein complexes). Cells expressing
E1A12S-DL-AS formed similar size tumors as cells expressing
E1A12S wt whereas cells expressing E1A12S-dl1132 formed
tumors of size in between cells expressing E1A12S wt and cells
expressing E1A12S-177-9. Since E1A12S wt and Ras transformed
cell lines did not induce tumor in new born rats as reported
(Subramanian et al., 1989), we made only qualitative determina-
tion of tumor formation in rats (Table 2). As expected, there was
no tumor in rats injected with E1A12S wt and Ras transformed
cells. Again transformed cells that express E1A12S-dl1133 cells
(88%) or mutant E1A12S-117-9 (76%) formed maximum percen-
tage of tumors. Cells expressing E1A12S-dl1132 formed tumors
only 50% of the total rats injected. Only 10% of the rats injected
with the cells expressing E1A12S-DL-AS formed tumors. These
tumors were also smaller in size compared to those induced by
cells that express other E1A mutants. Taken together, these results
suggest that the mutant E1A12S-DL-AS clearly showed enhanced
immortalization and Ras cooperative transformation, they were
not as tumorigenic as cells that express E1A12S-dl1133 or E1A12S-
117-9.CtBP interaction with E1A is needed for efﬁcient virus replication
Having determined the effect of CtBP interaction on the
transforming activities of E1A, we then determined the role of
E1A–CtBP interaction on viral replication. For this purpose, we
constructed an HAdv5 recombinant virus that expresses genomic
E1A harboring the DL-AS mutation and compared its replicative
potential with other E1A C-terminal mutants. Primary human
bronchial epithelial cells (HBEpC) and the human lung cancer cell
line, A549 were infected with different viruses and viral replica-
tion was determined by performing single step growth curves. In
HBEpC, replication of the C-terminal truncation mutant HAdv5-
177-9 was reduced about 5-fold compared to HAdv5-dl309 (wt).
Mutant HAdv5-dl1132 replicated to comparable levels as HAdv5-
dl309 whereas mutant HAdv5-dl1133 replicated at reduced levels
(Fig. 4A). The mutant HAdv5-DL-AS replicated about 3-fold lower
than wt. Since the mutants HAdv5-DL-AS and HAdv5-177-9
exhibited defects in viral replication, we analyzed the expression
of viral early and late genes in infected cells by Western blot
analysis (Fig. 4B). The C-terminal mutants, except HAdv5-177-9
expressed E1A proteins at levels comparable to that of HAdv5-
dl309 between 12 and 48 h post-infection. Mutant HAdv5-177-9
made reduced levels of E1A at 24 h post-infection and was not
readily detectable at late times of infection. The levels of other
early (E1B-19K, E2-DNA binding protein, E3-19K glycoprotein and
E4-ORF4) and late (ﬁber and capsid) proteins were lower in cells
infected with HAdv5-DL-AS than in wt (dl309)-infected cells.
Mutants HAdv5-dl1132 and HAdv5-dl1133 were not signiﬁcantly
defective in the expression of viral early and late genes. These
results suggest that interaction of CtBP with E1A C-terminal region
may be required for optimal activation of viral early and late genes.
In similar experiments with A549 cells, the virus replication in
general was about to 20 to 30-fold higher than in primary HBEpC.
In A549 cells also mutant HAdv5-DL-AS replicated less efﬁciently
than HAdv5-dl309. However, the replication defect of HAdv5-DL-
AS was less pronounced in A549 cells than in HBEpC cells. The
overall patterns of expression of viral early and late proteins were
also comparable to that observed in primary cells. The mutant
HAdv5-DL-AS expressed lower levels of various early and late
genes (Fig. 4D). Taken together, these results suggest that CtBP
interaction with E1A C-terminus is required for efﬁcient expres-
sion of viral genes and for virus replication.
Fig. 4. Effect of E1A C-terminal mutations on HAdv5 replication. (A) Replication in HBEpC. Cells (1106) were infected with 5 PFU/cell of HAdv5-dl309 (wt) or mutants and
the infected cells were frozen at every 12, 24, 36 and 48 h post-infection. The cells were thawed, sonicated, cleared and titrated on 293 cells. The experiment was done in
triplicate and the average virus yields were plotted. (B) Effect on expression of viral early and late genes. In separate experiments, the infected cells were lysed in an SDS-
sample buffer and analyzed by Western blotting for viral early and late proteins. (C) and (D) Experiments similar to (A) and (B) were repeated with human A549 cells.
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To further conﬁrm our results on the effect of CtBPs on virus
replication, we determined the levels of virus replication in human
U2OS cells that were stably depleted for CtBP1 or CtBP2. Pooled
cell lines transduced with lentiviral vectors that stably express
shRNA targets for CtBP1 or CtBP2 were established (Fig. 5A). The
infection of HAdv5-dl309 in cells depleted for CtBP2 resulted in
large plaques compared to the plaques on the parental U2OS cells
or CtBP1-depleted cells (Fig. 5B). The plaques produced by the
mutant HAdv5-DL-AS were relatively larger in CtBP2-depleted
cells than those in the parental U2OS cells or in CtBP1-depleted
cells. However, they were smaller than the plaques produced by
dl309 in CtBP2-depleted cells. We also tested virus replication in
CtBP-knockdown cells by infecting these cells with 5 pfu/cell of
HAdv5-dl309 or HAdv5-DL-AS. At 36 h of post-infection, the
virus yield was quantiﬁed by titrating on 293 cells (Fig. 5C). These
results indicated that dl309 replicated better in CtBP2-depleted
cells than in U2OS cells or CtBP1-depleted cells. Infection with the
mutant DL-AS resulted in about 10-fold reduction in virus yield
in U2OS cells and in CtBP1- or CtBP2-depleted cells compared to
HAdv5-dl309. The levels of expression of viral early and late
proteins (Fig. 5D) paralleled the levels of virus replication. Taken
together, the results presented in Fig. 5 suggests that knockdown
of CtBP2 in U2OS cells enhances the virus replication and the
inability of E1A to interact with CtBP (i.e., mutant DL-AS)
drastically retards virus replication.Discussion
HAdv E1A proteins have been extensively studied as model
viral transforming proteins and transcriptional regulators. Most
studies have concentrated on the N-terminal half of E1A proteins
(reviewed by Berk, 2005; Chinnadurai, 2011; Pelka et al., 2008). At
present, there is only a limited understanding of the functions
encoded by the C-terminal region of E1A which targets three
different cellular protein complexes. Here, we have investigated
the functional signiﬁcance of E1A interaction with one of the
protein complexes, CtBP1/2 by the use of a speciﬁc E1A mutant
(DL-AS) that obliterates the core CtBP binding motif PLDLS
(Schaeper et al., 1995).
Our current studies have shown that the DL-AS mutant of
E1A12S immortalized primary BRK cells better than E1A12S wt,
suggesting that the interaction of CtBP with the C-terminus
suppresses the immortalization function of E1A. Although it is
well known that E1A immortalizes primary rodent cells, immor-
talization of primary epithelial cells (e.g., BRK) by HAdv5 E1A is
generally inefﬁcient (while inducing efﬁcient Ras-cooperative
transformation). Our current results suggest that interaction of
CtBP with the E1A C-terminus may contribute to the inefﬁcient
immortalization by wt E1A. Previous gene expression proﬁling
studies have identiﬁed that CtBP suppresses the expression of
several pro-apoptotic genes (Grooteclaes et al., 2003). It is possible
that E1A may relieve CtBP-mediated repression of pro-apoptotic
genes in BRK cells leading to reduced immortalization. Consistent
Fig. 5. Effect of CtBPs knockdown on virus growth. (A) Western blot analysis of CtBP expression in U2OS and CtBP knockdown (indicated by↓arrow) cell lines. (B) Plaque
morphology of HAdv5-dl309 and HAdv5-DL-AS mutant in U2OS cell lines. Ten days after infection, the cells were stained with crystal violet and photographed. (C) Growth
of HAdv5-dl309 and HAdv5-DL-AS mutant. U2OS cell lines were infected with 5 pfu/cell of HAdv5-dl309 or HAdv5-DL-AS mutant. Thirty six hr post-infection, the virus
contents were titrated on 293 cells. (D) Expression of viral early and late proteins. Cells were infected with wt and mutant viruses and the expression early and late proteins
were analyzed at the indicated time points by western blots.
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in BRK cells transduced with wt E1A-12S compared to cells
transduced with E1A 12S-DL-AS mutant (results not shown).
Our results also indicated that the DL-AS mutant enhanced
Ras-cooperative transformation, suggesting that CtBP interaction
with E1A suppresses the transforming activity of E1A as well. It is
possible that the cellular pathways deregulated by E1A–CtBP
interaction that contribute to the suppression of immortalization
may also suppress Ras-cooperative transformation. In addition to
proliferation and apoptotic pathways deregulated as a result of
E1A–CtBP interaction, deregulation of cell differentiation may also
contribute the effect on cell transformation. CtBP has been
reported to repress several epithelial genes that were relieved as
a result of interaction with E1A (Grooteclaes et al., 2003;
Grooteclaes and Frisch, 2000). It is somewhat surprising that
transformed cells that express the DL-AS mutant is not more
tumorigenic than transformed cells that express E1A 12S wt.
Previous results with E1A mutants that are defective in interaction
with DYRK1/HAN11 and CtBP1/2 complexes (e.g., dl1135) (Boyd
et al., 1993) or with all three protein complexes (mutants 177-9
and 177-E) (Subramanian et al., 1989) revealed that transformed
cells that express these mutants were highly tumorigenic both inathymic mice and in syngeneic rats. Thus, E1A mutants defective
in interaction with DYRK1/HAN11 and FOXK1/K2 appear to inﬂu-
ence the tumorigenic activity rather that the mutant defective in
interaction with only CtBP. Thus, interaction of three different
protein complexes with E1A C-terminal region may regulate cell
transformation and oncogenesis in a non-redundant fashion.
Our results suggest that the interaction of CtBP with E1A
enhances viral early and late gene expression and viral replication.
Although the precise mechanism for the role of CtBP-mediated
effect on viral replication remains to be investigated in detail, two
different scenarios could be envisioned. In cells infected with the
viral mutant HAdv5-DL-AS the expression of viral early gene
products was reduced. We have also observed that in transient
reporter based assays the trans-activation of viral E3 and E4
promoters was reduced in cells transfected with genomic E1A
carrying DL-AS mutation (not shown). The effect of E1A C-
terminus on the trans-activation of viral early genes (that is
primarily mediated by the CR3 trans-activation domain of E1A)
is unexpected. A previous study (Bruton et al., 2008) has reported
that CtBP also interacted with the CR3 trans-activation domain
through a motif related to the second CtBP-binding motif known
as the RRT motif (Quinlan et al., 2006) retarding the overall trans-
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CtBP with the C-terminus may relieve the negative effect of CtBP
on CR3-mediated trans-activation. Alternatively, CtBP interaction
with E1A may enhance the ‘epithelialness' of the target cells by
relieving CtBP-mediated repression of cellular epithelial target
genes. The change in epithelialness may provide more suitable
cellular environment for HAdv5 replication. Both scenarios may be
consistent with a previous observation that siRNA-mediated
depletion of CtBP1/2 resulted in enhanced viral replication in
human cells (Grand et al., 2007)). Our results suggest that CtBP2
depletion enhances viral replication (Fig. 5). The relative enhance-
ment in viral replication may be an underestimate since CtBP1
may also negatively inﬂuence virus replication, in the absence of
CtBP2, as CtBP1 and CtBP2 are known to exhibit functional
redundancy under certain conditions (Hildebrand and Soriano,
2002). Detailed genomic studies may be warranted to identify
CtBP regulated genes in HAdv5 infected cells and to determine
their role in viral gene expression and replication.Materials and methods
Cells
Baby rat kidney (BRK) cells were prepared from 2-day old
neonatal rats (Subramanian et al., 1989) and grown in Dulbecco's
modiﬁed Eagle's medium (DMEM) with 10% fetal bovine serum.
Normal human bronchial epithelial cells (HBEpC) were purchased
from Cambrex, USA and grown in bronchial epithelial cell growth
medium (Lonza Walkersville, Inc.). HeLa, A549, U2OS and 293 cells
were grown in DMEM containing 10% fetal bovine serum.Plasmids and viruses
The plasmids p12S, p12S-dl1132, p12S-dl1133, p12S-177-9,
pBABEpuro, pBABE-12S, pBABE-dl1132 and pBABE-dl1133 were
described previously (Komorek et al., 2010). Plasmids pBABE-
177-9, p12S-DL-AS and pBABE12S-DL-AS were constructed by
oligo nucleotide directed mutagenesis. Plasmids CtBP1shRNA2/pL6
and CtBP2shRNA1/pL7 were generous gifts from Madison and
Lundblad (2010).
For the construction of HAdv5-DL-AS mutant virus, the
plasmid, pE1A (nucleotide 1 to 1770 containing genomic E1A of
HAdv5 in pUC19) was mutated to change residues D281 and L282
to A and S using an oligo nucleotide directed mutagenesis kit from
Stratagene. The resulting plasmid pE1A-DL-AS was co-
transfected with the HAdv5 genomic plasmid pBHGE3 (Bett
et al., 1994) onto human 293 cells and the cells were maintained
in DMEM containing 2% fetal bovine serum until clear cytopathic
effects were seen. The cells were freeze thawed three times and
the supernatant was plaque assayed on 293 cells. Plaques were
screened for the mutation by restriction analysis and conﬁrmed by
DNA sequencing. The mutant virus (HAdv5-DL-AS) was puriﬁed
by CsCl banding and titrated on 293 cells. In a similar way the
p12S-177-9 mutation (Subramanian et al., 1989) was introduced
into the E1A plasmid and the virus (HAdv5-177-9 (Δ224–284 aa in
13S product)) was constructed as described above. The genomic
version of mutants HAdv5-dl1132 and HAdv5-dl1133 have been
described previously (Jelsma et al., 1989; Mymryk and Bayley,
1993). The plasmids/retrovirus vectors and HAdv5 viral mutants
harboring different E1A mutations and their defect in interaction
with cellular proteins are listed in Table 1.Immortalization
Retrovirus vectors (pBABE) expressing E1A12S or E1A12S
mutants or empty vector were pseudotyped in Phoenix E retro-
virus packaging cell line. Forty-eight hour after transfection, the
supernatant containing retroviruses were used to infect BRK cells
in six-well plates. Twenty-four hour after infection, cells were
selected with 0.25 mg/mL of puromycin for 10 days. Every fourth
day, the medium was replaced with fresh medium containing
puromycin. At the end of 10 days, colonies were stained with
crystal violet, photographed and counted. In the second set of
experiments, 24 puromycin selected colonies were randomly
picked from retrovirus-transduced cells and plated in 24-well
plates with 1 mL of growth medium. The growth medium was
replaced with fresh medium every fourth day and the cells were
stained with crystal violet after four weeks. The total number of
wells with proliferated cells were counted and considered as
immortalized.
Ras co-operative transformation and tumorigenesis
Primary BRK cells were plated in six-well plates with 2.0 mL of
DMEM containing 10% fetal bovine serum one day prior to
transfection. Each well was transfected with 1.0 mg of E1A12S or
mutants, 1.0 mg of pUC18-Ras and 1.0 mg of pcDNA3 (Invitrogen),
using jetPEI (Polyplus) transfection reagent according to the
manufacturer's speciﬁcation. Twenty-four hour post-transfection,
cells were selected with 50.0 mg/mL of G418 for 10 days and
stained with crystal violet, the transformed colonies were counted
and plotted. To establish cell lines, another batch of transfected
BRK cells were selected with G418, the colonies from each
transfectant were pooled and grown as a pooled cell line. The
established cell lines were tested for their tumorigenesity in
athymic mice and two-day-old neonatal rats. Each athymic mice
were subcutaneously injected with 1106 cells in 100.0 mL of
DMEM without serum and the tumor volumes were measured
every ﬁfth day for 20 days. For neonatal rats, 1106 cells in
50.0 mL of DMEM without serum were injected subcutaneously.
At the end of 3 weeks period, all the rats were euthanized and the
number of tumor bearing rats was counted.
Establishment of CtBP knockdown cell lines
The human 293T cell line was transfected with lentiviral
vectors expressing shRNAs against CtBP1 (CtBP1shRNA2/pL6) or
CtBP2 (CtBP2shRNA/pL7) along with lentivirus packaging plas-
mids. After 48 h of transfection, the supernatant containing
lentivirus was collected and used for infecting the human U2OS
cell line. The infected cells were selected with 6 mg/mL of blas-
ticidin for CtBP1 knockdown or 300 mg/mL of hygromycin for
CtBP2 knockdown. The selected colonies were pooled, tested for
the expression of CtBP1 and 2 and established as cell lines.
Virus growth
The human cells (A549 and HBEpC) were infected with 5 PFU/
cell of HAdv5-dl309 or genomic versions of different E1A mutant
viruses (DL-AS, dl1132, dl1133 or 177-9). After 1 h incubation at
37 1C, cells were washed three times with 2.5 mL of DMEM
containing 2% fetal bovine serum and replaced with 2.5 mL of
DMEM containing 2% fetal bovine serum. At the indicated times
after infection, cells were frozen and the virus contents were
titrated on 293 cells. In another set of experiments, the virus
infected cells were lysed in an SDS-sample buffer and subjected to
PAGE and western blot analyses of adenoviral early and late
proteins.
T. Subramanian et al. / Virology 443 (2013) 313–320320Immunoprecipitation and western blot analysis
Transiently transfected HeLa cells (24 h after of transfection) or
established BRK cells were lysed and cleared by centrifugation. The
clear cell lysates were incubated with anti-E1A mAb (M58; BD
Biosciences) overnight and the bound protein complexes were
pulled with protein A agarose beads. The immunoprecipitated
protein complexes and cell lysates were resolved by SDS-PAGE and
analyzed by Western blot using antibodies against indicated
proteins (E1A, CtBP1, CtBP2, FOXK1 and DYRK1A). For Western
blot analysis of viral structural proteins, human cells in 35 mm
dishes were infected with 5 PFU/cell of wt HAdv5 (dl309) or
mutants. At the indicated times after infection, cells were lysed in
300 mL of an SDS-sample buffer and Western blots were carried
out using antibodies speciﬁc to viral early and late proteins.Acknowledgments
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